SCHEMBL13999965

SCHEMBL13999965

c1ccc(-c2ccccc2-c2nc3ccccc3n2-c2cccc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4ccccc34)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.44
MAPK10 P53779 3/20 0.42
RAB9A P51151 1/20 0.42
ESR1 P03372 3/20 0.41
ESR2 Q92731 3/20 0.41
GAA P10253 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MET P08581 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
HPGD P15428 3/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
RPS6KB1 P23443 1/20 0.38
PDE10A Q9Y233 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13999932 0.92 ESR1 (0.48) RECQLMAPK10RAB9AESR1ESR2
SCHEMBL24810865 0.92 ESR1 (0.50) MAPK10ESR1ESR2GAAMEN1
SCHEMBL14000372 0.92 RECQL (0.47) RECQLRAB9AESR1ESR2GAA
SCHEMBL24811900 0.91 RECQL (0.49) RECQLMAPK10RAB9AESR1ESR2
SCHEMBL13999974 0.91 ESR1 (0.49) MAPK10ESR1ESR2GAAMEN1
SCHEMBL14363301 0.91 RECQL (0.48) RECQLRAB9AESR1ESR2GAA
SCHEMBL25668121 0.90 ESR1 (0.48) MAPK10ESR1ESR2GAAMEN1
SCHEMBL13999915 0.90 RECQL (0.45) RECQLRAB9AESR1ESR2GAA
SCHEMBL14000007 0.90 RECQL (0.47) RECQLRAB9AESR1ESR2GAA
SCHEMBL13999925 0.90 RECQL (0.41) RECQLMAPK10RAB9AESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2000464-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME Idemitsu Kosan Co., Ltd. (JP) 2008-12-10 EP disclosed
US-20070267970-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-11-22 US disclosed
US-20070267970-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070267970-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME NUDC, NUDT1, SLC43A1 RECQL 1618/4885MAPK10 2323/4885RAB9A 1770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.